trending Market Intelligence /marketintelligence/en/news-insights/trending/8r817SBkEjhfTe9Dfnafpw2 content esgSubNav
In This List

Humana acquiring hospice pharmacy, benefit management provider Enclara

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints

Blog

Shore Capital is Now Available in S&P Global’s Aftermarket Research Collection


Humana acquiring hospice pharmacy, benefit management provider Enclara

Humana Inc. agreed to acquire privately held hospice pharmacy and benefit management provider Enclara Healthcare from Consonance Capital Partners and Enclara management.

The transaction includes the acquisition of Enclara Pharmacia, GuidantRx and Avanti Health Care Services. Financial terms of the transaction were not disclosed, and certain assets are excluded.

The transaction is expected to have an immaterial impact to Humana's earnings in 2020. It is anticipated to close during the first half of 2020 and is subject to customary state and federal regulatory approvals as well as other customary closing conditions.

Enclara serves over 450 hospice providers and 97,000 hospice patients per day.

Centerview Partners LLC is serving as financial adviser to Humana. Crowell & Moring LLP is acting as legal adviser to Humana. Evercore Inc. is acting as financial adviser to Enclara and Consonance Capital. Latham & Watkins LLP is acting as legal adviser to Enclara and Consonance Capital.